In this frame, our data indicate that PTX3 secreted by tumor cells promotes the activation of the TLR4/IRAK1 pathway in TNBC cells, and that the expression of PTX3 itself may determine the antitumor responses to TLR4 inhibition. This evidence concerns the gene PTX3 and neoplasm.